BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4214761)

  • 1. Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.
    Bitter-Suermann D; Dierich M; König W; Hadding U
    Immunology; 1972 Sep; 23(3):267-81. PubMed ID: 4214761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    Ballow M; Cochrane CG
    J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
    [No Abstract]   [Full Text] [Related]  

  • 3. Formation and function of a complement-activating enzyme generated from factors of guinea pig serum and cobra venom.
    Dierich MP; Bitter-Suermann D; König W; Hadding U
    Eur J Immunol; 1971 Aug; 1(4):309-11. PubMed ID: 5157967
    [No Abstract]   [Full Text] [Related]  

  • 4. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V; Nicholson A; Lee GD; Mayer MM
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract]   [Full Text] [Related]  

  • 5. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
    Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
    J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation.
    Fearon DT; Austen KF; Ruddy S
    J Immunol; 1973 Dec; 111(6):1730-6. PubMed ID: 4796101
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.
    Müller-Eberhard HJ; Fjellström KE
    J Immunol; 1971 Dec; 107(6):1666-72. PubMed ID: 5120401
    [No Abstract]   [Full Text] [Related]  

  • 8. Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.
    Brade V; Nicholson A; Bitter-Suermann D; Hadding U
    J Immunol; 1974 Dec; 113(6):1735-43. PubMed ID: 4279261
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation and characterization of the proenzyme form of the C1s subunit of the first complement component.
    Valet G; Cooper NR
    J Immunol; 1974 Jan; 112(1):339-50. PubMed ID: 4204604
    [No Abstract]   [Full Text] [Related]  

  • 10. C3b inactivator of man. 3. Further purification and production of antibody to C3b INA.
    Ruddy S; Hunsicker LG; Austen KF
    J Immunol; 1972 Mar; 108(3):657-64. PubMed ID: 4622188
    [No Abstract]   [Full Text] [Related]  

  • 11. A starfish hemolymph factor which activates vertebrate complement in the presence of cobra venom factor.
    Day N; Geiger H; Finstad J; Good RA
    J Immunol; 1972 Jul; 109(1):164-7. PubMed ID: 4624674
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.
    Kay AB
    Clin Exp Immunol; 1970 Nov; 7(5):723-37. PubMed ID: 4992784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effect of various antisera and cobra venom factor on inflammatory reactions in guinea-pig skin. II. The Arthus reaction and the local Shwartzman reaction.
    Lewis E; Turk JL
    J Pathol; 1975 Feb; 115(2):111-25. PubMed ID: 125318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).
    Brade V; Cook CT; Shin HS; Mayer MM
    J Immunol; 1972 Dec; 109(6):1174-81. PubMed ID: 4628703
    [No Abstract]   [Full Text] [Related]  

  • 15. A factor in guinea-pig serum with accelerating effect on immune immobilization of Treponema pallidum (IAF). Isolation, purification and differentiation from the known haemolytic complement components and from lysozyme.
    Müller F; Segerling M
    Immunology; 1974 Jul; 27(1):33-41. PubMed ID: 4604004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase isoenzymes from Naja naja venom. I. Purification and partial characterization.
    Shiloah J; Klibansky C; De Vries A
    Toxicon; 1973 Oct; 11(6):481-90. PubMed ID: 4202693
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.
    Volanakis JE; Kaplan MH
    J Immunol; 1974 Jul; 113(1):9-17. PubMed ID: 4208926
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.
    Cochrane CG; Müller-Eberhard HJ; Aikin BS
    J Immunol; 1970 Jul; 105(1):55-69. PubMed ID: 4246566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.